Identification and Validation of METTL3-Related Molecules for Predicting Prognosis and Efficacy of Immunotherapy in Gastric Cancer Based on m6A Methylome and Transcriptome Sequencing Analysis

MLA

Shuran Chen, et al. “Identification and Validation of METTL3-Related Molecules for Predicting Prognosis and Efficacy of Immunotherapy in Gastric Cancer Based on M6A Methylome and Transcriptome Sequencing Analysis.” Frontiers in Oncology, vol. 12, July 2022. EBSCOhost, https://doi.org/10.3389/fonc.2022.935239.

APA

Shuran Chen, Xu Su, Jing Wang, Ni Zheng, Yuan Tang, Guisen Peng, Rui Dong, Fei Lu, Mulin Liu, Yunli Zhao, & Huazhang Wu. (2022). Identification and Validation of METTL3-Related Molecules for Predicting Prognosis and Efficacy of Immunotherapy in Gastric Cancer Based on m6A Methylome and Transcriptome Sequencing Analysis. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.935239

Chicago

Shuran Chen, Xu Su, Jing Wang, Ni Zheng, Yuan Tang, Guisen Peng, Rui Dong, et al. 2022. “Identification and Validation of METTL3-Related Molecules for Predicting Prognosis and Efficacy of Immunotherapy in Gastric Cancer Based on M6A Methylome and Transcriptome Sequencing Analysis.” Frontiers in Oncology 12 (July). doi:10.3389/fonc.2022.935239.